CLAIRE THOMPSON

Chief Executive Officer, Agility Life Sciences

Claire is an award-winning scientist, strategist and innovator with more than 15 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer, virtual and Contract Research Organisations. She is Deputy Chief Scientist of the Royal Pharmaceutical Society. She is also the CEO of Agility Health Tech, a consulting and communications firm which works with organisations across the healthcare space to advance their products and raise their profile.

Having taken a range of therapeutic products through clinical Phases 1 to 3, she thrives on translating innovative technologies into healthcare products and shaping technical and organisational strategies. She was honoured with the Royal Pharmaceutical Society’s Pharmaceutical Science Award in 2015, and the Academy of Pharmaceutical Sciences’ Medal in 2016.

Before founding Agility Health Tech, she was Head of R&D with Oxford PharmaScience, an AIM-listed virtual Pharmaceutical company identified as one of the “Top 10 Emerging Technology Companies 2012”. Prior to this, Claire was Associate Director at Molecular Profiles (now Juniper Pharmaceuticals) and spent 7½ years at GlaxoSmithKline and Pfizer developing novel molecules and formulations for therapeutic areas such as asthma, cancer, HIV, insomnia, malaria and pain.

 LIVE ONLINE

16 November 2020

BOOK YOUR PLACE NOW

 LIVE ONLINE

17 November 2020

BOOK YOUR PLACE NOW